Screening assay for blood vessel maturation inhibitors

Biochemical and Biophysical Research Communications

Volumn 438, Issue 2, 2013, Pages 364-369

  Fu, Chenglai ^a   van der Zwan, Anita ^a,b   Gerber, Stephanie ^a   Van Den Berg, Susan ^a,b   No, Elisa ^a   C H Wang, Wayne ^c   Sheibani, Nader ^d   Carducci, Michael A ^a   Kachhap, Sushant ^a   Hammers, Hans J ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Angiogenesis model; Blood vessel maturation; Drug screening; Endoglin; Imatinib; Pericyte; Sunitinib

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; VASCULOTROPIN;

ARTICLE; BLOOD VESSEL; CANCER PATIENT; CELL ASSAY; CELL DIFFERENTIATION; CONTROLLED STUDY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; INFORMATION PROCESSING; MATURATION; MESENCHYMAL STEM CELL; PERICYTE; PRIORITY JOURNAL; SCREENING; UMBILICAL VEIN ENDOTHELIAL CELL;

ANGIOGENESIS MODEL; BLOOD VESSEL MATURATION; DRUG SCREENING; ENDOGLIN; IMATINIB; PERICYTE; SUNITINIB;

ACTINS; ANGIOGENESIS INHIBITORS; ANIMALS; BENZAMIDES; BLOOD VESSELS; CELL LINE; COCULTURE TECHNIQUES; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL CELLS; FIBROBLASTS; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INDOLES; LENTIVIRUS; MICE; MUSCLE, SMOOTH; NEOVASCULARIZATION, PHYSIOLOGIC; PERICYTES; PIPERAZINES; PROMOTER REGIONS, GENETIC; PYRIMIDINES; PYRROLES; STEM CELLS;

EID: 84882579515     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.07.077     Document Type: Article

References (22)

1. Bergers G., Hanahan D. Modes of resistance to anti-angiogenic therapy. Nat. Rev. Cancer 2008, 8:592-603.
2. Franco M., Roswall P., Cortez E., Hanahan D., Pietras K. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Blood 2011, 118:2906-2917.
3. Koh W., Stratman A.N., Sacharidou A., Davis G.E. In vitro three dimensional collagen matrix models of endothelial lumen formation during vasculogenesis and angiogenesis. Methods Enzymol. 2008, 443:83-101.
4. Stratman A.N., Davis M.J., Davis G.E. VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines. Blood 2011, 117:3709-3719.
5. Scheef E.A., Sorenson C.M., Sheibani N. Attenuation of proliferation and migration of retinal pericytes in the absence of thrombospondin-1. Am. J. Physiol. Cell Physiol. 2009, 296:C724-734.
6. Kutner R.H., Zhang X.Y., Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat. Protoc. 2009, 4:495-505.
7. Bishop E.T., Bell G.T., Bloor S., Broom I.J., Hendry N.F., Wheatley D.N. An in vitro model of angiogenesis: basic features. Angiogenesis 1999, 3:335-344.
8. Brave S.R., Eberlein C., Shibuya M., Wedge S.R., Barry S.T. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model. Angiogenesis 2010, 13:337-347.
9. Evensen L., Micklem D.R., Blois A., Berge S.V., Aarsaether N., Littlewood-Evans A., Wood J., Lorens J.B. Mural cell associated VEGF is required for organotypic vessel formation. PLoS One 2009, 4:e5798.
10. Darland D.C., D'Amore P.A. TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis 2001, 4:11-20.
11. Hirschi K.K., Rohovsky S.A., D'Amore P.A. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 1998, 141:805-814.
12. Kale S., Hanai J., Chan B., Karihaloo A., Grotendorst G., Cantley L., Sukhatme V.P. Microarray analysis of in vitro pericyte differentiation reveals an angiogenic program of gene expression. FASEB J. 2005, 19:270-271.
13. Arora P.D., Narani N., McCulloch C.A. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am. J. Pathol. 1999, 154:871-882.
14. Jain R.K. Molecular regulation of vessel maturation. Nat. Med. 2003, 9:685-693.
15. Stratman A.N., Schwindt A.E., Malotte K.M., Davis G.E. Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization. Blood 2010, 116:4720-4730.
16. Abramsson A., Lindblom P., Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J. Clin. Invest. 2003, 112:1142-1151.
17. Faivre S., Demetri G., Sargent W., Raymond E. Molecular basis for sunitinib efficacy and future clinical development. Nat. Rev. Drug Discov. 2007, 6:734-745.
18. Keisner S.V., Shah S.R. Pazopanib: the newest tyrosine kinase inhibitor for the treatment of advanced or metastatic renal cell carcinoma. Drugs 2011, 71:443-454.
19. Cascone T., Herynk M.H., Xu L., Du Z., Kadara H., Nilsson M.B., Oborn C.J., Park Y.Y., Erez B., Jacoby J.J., Lee J.S., Lin H.Y., Ciardiello F., Herbst R.S., Langley R.R., Heymach J.V. Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor-resistant human lung adenocarcinoma. J. Clin. Invest. 2011, 121:1313-1328.
20. ten Dijke P., Arthur H.M. Extracellular control of TGFbeta signalling in vascular development and disease. Nat. Rev. Mol. Cell Biol. 2007, 8:857-869.
21. Li D.Y., Sorensen L.K., Brooke B.S., Urness L.D., Davis E.C., Taylor D.G., Boak B.B., Wendel D.P. Defective angiogenesis in mice lacking endoglin. Science 1999, 284:1534-1537.
22. McAllister K.A., Grogg K.M., Johnson D.W., Gallione C.J., Baldwin M.A., Jackson C.E., Helmbold E.A., Markel D.S., McKinnon W.C., Murrell J., et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat. Genet. 1994, 8:345-351.